Enzalutamide is an androgen receptor inhibitor, belonging to the class of antiandrogen drugs and hormone/antitumor drugs.
Hot flashes are a common adverse reaction of enzalutamide, manifesting as sudden sensations of heat in the face, neck, and chest, which may be accompanied by sweating and palpitations.
Management measures include: wearing loose, breathable cotton clothing and layering clothes for easy adjustment; avoiding triggers such as spicy foods, alcohol, caffeine, and overheated environments; keeping the environment cool and carrying a fan or cool towel; when symptoms are pronounced, symptomatic treatment may be given under the guidance of a physician, and whether dose adjustment is needed should be evaluated when necessary.
Most hot flashes are mild to moderate and may gradually diminish with prolonged treatment.
Enzalutamide may cause fatigue, dizziness, orthostatic hypotension, and musculoskeletal pain, increasing the risk of falls, especially in elderly patients.
Preventive measures include: moving slowly when getting up and changing position, avoiding sudden standing; keeping household pathways clear and well lit, and installing non-slip mats and grab bars in the bathroom; avoiding alcohol and excessive fatigue; monitoring blood pressure regularly, and promptly informing the physician if significant hypotension or dizziness occurs; performing balance assessment and assisted walking when necessary.
If a fall occurs, the circumstances of the fall should be recorded and medical attention should be sought to investigate the cause.
Enzalutamide may cause cognitive changes such as decreased attention, memory decline, and slowed thinking, and in severe cases may cause confusion.
Management measures include: family members should watch for changes in the patient's cognitive status before and during treatment, and a brief cognitive assessment should be performed when necessary; maintaining a regular schedule and moderate mental activity; avoiding concomitant use of drugs that may worsen cognitive impairment (such as sedative-hypnotics); if symptoms are pronounced or progressively worsening, the physician should be informed promptly to evaluate whether drug suspension, dose reduction, or further examination is needed.
Most cognitive changes improve after discontinuation or dose reduction.
Disclaimer:《Enzalutamide side effect management: how to deal with hot flashes, falls, and cognitive impairment》Edited and sorted by Seagull Pharmacy's editors. Please contact us in time if there is any infringement. In addition, the suggestions for drug usage, dosage and disease mentioned in the article are only for medical staff's reference, and can not be used as any basis for medication!
Full Name:Enzalutamide、Xtandi、MDV 3100、恩杂鲁胺、恩扎卢胺、安可坦
Reference Price:$1350.00
Prescribing Information: 恩杂鲁胺是一种雄激素受体抑制剂,属于抗雄激素类药物和激素/抗肿瘤药物类别。 一、药品名称 恩杂鲁胺(Xtandi,Enzalutamide)。 二、适应症 用于治疗既往接受过多西他赛治疗的转移性去势耐受性前列腺癌患者。 三、规格 规格为40mg胶囊。 ...